IL147505A0 - Neurotrophic pyrrolidines and piperidines, and related compositions and methods - Google Patents
Neurotrophic pyrrolidines and piperidines, and related compositions and methodsInfo
- Publication number
- IL147505A0 IL147505A0 IL14750500A IL14750500A IL147505A0 IL 147505 A0 IL147505 A0 IL 147505A0 IL 14750500 A IL14750500 A IL 14750500A IL 14750500 A IL14750500 A IL 14750500A IL 147505 A0 IL147505 A0 IL 147505A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrrolidines
- piperidines
- neurotrophic
- methods
- related compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14300699P | 1999-07-09 | 1999-07-09 | |
PCT/US2000/016221 WO2001004116A2 (fr) | 1999-07-09 | 2000-06-14 | Pyrrolidines et piperidines neurotrophiques et compositions et procedes correspondants |
Publications (1)
Publication Number | Publication Date |
---|---|
IL147505A0 true IL147505A0 (en) | 2002-08-14 |
Family
ID=22502172
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14750500A IL147505A0 (en) | 1999-07-09 | 2000-06-14 | Neurotrophic pyrrolidines and piperidines, and related compositions and methods |
IL147505A IL147505A (en) | 1999-07-09 | 2002-01-07 | Pyrolidines and neurotrophic piperidines and their use in the preparation of drugs containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL147505A IL147505A (en) | 1999-07-09 | 2002-01-07 | Pyrolidines and neurotrophic piperidines and their use in the preparation of drugs containing them |
Country Status (17)
Country | Link |
---|---|
US (1) | US6809107B1 (fr) |
EP (1) | EP1202990A2 (fr) |
JP (1) | JP2003504367A (fr) |
KR (1) | KR20020027486A (fr) |
CN (1) | CN1382140A (fr) |
AR (1) | AR034541A1 (fr) |
AU (1) | AU781235B2 (fr) |
BR (1) | BR0012327A (fr) |
CA (1) | CA2379149A1 (fr) |
CZ (1) | CZ200265A3 (fr) |
HU (1) | HUP0202249A3 (fr) |
IL (2) | IL147505A0 (fr) |
MX (1) | MXPA02000330A (fr) |
PL (1) | PL352432A1 (fr) |
RU (1) | RU2241709C2 (fr) |
TW (1) | TW589311B (fr) |
WO (1) | WO2001004116A2 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2835254B1 (fr) * | 2002-01-25 | 2006-04-07 | Sod Conseils Rech Applic | Derives de thiazoles dans le traitement de maladies neurologiques |
DE10240818A1 (de) * | 2002-08-30 | 2004-05-13 | Grünenthal GmbH | Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate |
SI1551835T1 (sl) * | 2002-09-30 | 2007-06-30 | Neurosearch As | Novi 1,4-diazabicikloalkanski derivati, njihova priprava in uporaba |
US7189746B2 (en) * | 2002-11-08 | 2007-03-13 | Gliamed, Inc. | Methods for promoting wound healing |
US20040266811A1 (en) * | 2002-11-08 | 2004-12-30 | Weinstein David E. | Methods for inducing regeneration, remyelination, and hypermyelination of nervous tissue |
WO2006116808A1 (fr) * | 2005-04-29 | 2006-11-09 | Metabolic Pharmaceuticals Limited | Traitement de neuropathies périphériques |
US20080015236A1 (en) * | 2006-02-08 | 2008-01-17 | Weinstein David E | Method for promoting myocardial regeneration and uses thereof |
US7795216B2 (en) * | 2006-03-24 | 2010-09-14 | Glia Med, Inc. | Methods for promoting composite tissue regeneration and uses thereof |
GB0701426D0 (en) * | 2007-01-25 | 2007-03-07 | Univ Sheffield | Compounds and their use |
TWI534142B (zh) * | 2011-03-15 | 2016-05-21 | 大正製藥股份有限公司 | Azole derivatives |
ES2788848T3 (es) * | 2013-09-06 | 2020-10-23 | Aurigene Discovery Tech Ltd | Derivados de 1,2,4-oxadiazol como inmunomoduladores |
AU2015367531B2 (en) * | 2014-12-17 | 2020-04-30 | King's College London | Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARbeta) agonists |
KR102102837B1 (ko) * | 2015-12-04 | 2020-04-22 | 더 펜 스테이트 리서어치 파운데이션 | 소분자 혼합제를 이용한 인간 교세포의 뉴런으로의 화학적 리프로그래밍 |
CN114591295B (zh) * | 2022-03-04 | 2023-11-07 | 贵州大学 | 含吡啶盐的n-(吲哚酰基)-n’-(取代的)的丙基酰肼类衍生物、其制备方法及应用 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950649A (en) | 1980-09-12 | 1990-08-21 | University Of Illinois | Didemnins and nordidemnins |
DE3721534A1 (de) * | 1986-08-02 | 1988-02-11 | Basf Ag | Thiadiazolgruppen enthaltende polymere und deren verwendung in der elektroindustrie |
AU1995792A (en) | 1991-05-09 | 1992-12-21 | Vertex Pharmaceuticals Incorporated | Novel immunosuppressive compounds |
US5621101A (en) | 1992-07-24 | 1997-04-15 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
US5756494A (en) | 1992-07-24 | 1998-05-26 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
US5461146A (en) | 1992-07-24 | 1995-10-24 | Cephalon, Inc. | Selected protein kinase inhibitors for the treatment of neurological disorders |
NZ314207A (en) | 1992-09-28 | 2000-12-22 | Vertex Pharma | 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers |
US5798355A (en) | 1995-06-07 | 1998-08-25 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity |
DE69534300T2 (de) | 1994-08-18 | 2006-05-18 | Ariad Gene Therapeutics, Inc., Cambridge | Neues multimerisierendes reagenz |
US5696135A (en) | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
US5859031A (en) | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
US5614547A (en) | 1995-06-07 | 1997-03-25 | Guilford Pharmaceuticals Inc. | Small molecule inhibitors of rotamase enzyme |
US5801197A (en) | 1995-10-31 | 1998-09-01 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
ATE465149T1 (de) | 1996-02-28 | 2010-05-15 | Ariad Pharma Inc | Synthetische rapamycinderivate als multimerisierende wirkstoffe für chimere proteine mit von immunophilin abgeleiteten domänen |
US5801187A (en) | 1996-09-25 | 1998-09-01 | Gpi-Nil Holdings, Inc. | Heterocyclic esters and amides |
US5786378A (en) | 1996-09-25 | 1998-07-28 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters |
US5780484A (en) | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
PA8442401A1 (es) | 1996-12-09 | 2000-05-24 | Guilford Pharm Inc | Inhibidores polipropilos de ciclofilina |
US5935989A (en) | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
US5874449A (en) | 1996-12-31 | 1999-02-23 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of heterocyclic thioesters |
US5721256A (en) | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
ZA98825B (en) * | 1997-02-27 | 1998-10-19 | Guilford Pharm Inc | Method of using neurotrophic carbamates and ureas |
US5846979A (en) | 1997-02-28 | 1998-12-08 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic esters, amides, thioesters, and ketones |
JP2001516767A (ja) * | 1997-09-24 | 2001-10-02 | アムジエン・インコーポレーテツド | 感覚神経向性化合物を使用する難聴の予防及び治療法 |
GB9804426D0 (en) | 1998-03-02 | 1998-04-29 | Pfizer Ltd | Heterocycles |
HUP0102532A3 (en) * | 1998-06-03 | 2002-06-28 | Gpi Nil Holdings Inc Wilmingto | Aza-heterocyclic compounds used to treat neurological disorders and hair loss and process for their preparation and pharmaceutical compositions containing them |
DE69837564T2 (de) * | 1998-06-03 | 2007-12-27 | Gliamed, Inc. | Azaheterozyklische derivate zur behandlung von haarausfall und neurologischer krankheiten |
CN1299346A (zh) * | 1998-06-03 | 2001-06-13 | Gpi;Nil控股公司 | N-杂环羧酸或羧酸等排物的脲和氨基羧酸酯 |
US6331537B1 (en) | 1998-06-03 | 2001-12-18 | Gpi Nil Holdings, Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
US6284779B1 (en) | 1999-02-03 | 2001-09-04 | Schering Aktiiengesellschaft | Heteroaromatic compounds |
-
2000
- 2000-06-14 BR BR0012327-7A patent/BR0012327A/pt not_active Application Discontinuation
- 2000-06-14 HU HU0202249A patent/HUP0202249A3/hu unknown
- 2000-06-14 CA CA002379149A patent/CA2379149A1/fr not_active Abandoned
- 2000-06-14 MX MXPA02000330A patent/MXPA02000330A/es unknown
- 2000-06-14 CN CN00812744A patent/CN1382140A/zh active Pending
- 2000-06-14 AU AU54855/00A patent/AU781235B2/en not_active Ceased
- 2000-06-14 CZ CZ200265A patent/CZ200265A3/cs unknown
- 2000-06-14 JP JP2001509726A patent/JP2003504367A/ja active Pending
- 2000-06-14 RU RU2002103340/04A patent/RU2241709C2/ru not_active IP Right Cessation
- 2000-06-14 IL IL14750500A patent/IL147505A0/xx active IP Right Grant
- 2000-06-14 PL PL00352432A patent/PL352432A1/xx not_active Application Discontinuation
- 2000-06-14 KR KR1020027000348A patent/KR20020027486A/ko not_active Application Discontinuation
- 2000-06-14 US US09/593,852 patent/US6809107B1/en not_active Expired - Lifetime
- 2000-06-14 WO PCT/US2000/016221 patent/WO2001004116A2/fr not_active Application Discontinuation
- 2000-06-14 EP EP00939836A patent/EP1202990A2/fr not_active Withdrawn
- 2000-07-07 AR ARP000103484A patent/AR034541A1/es unknown
- 2000-09-18 TW TW089113459A patent/TW589311B/zh not_active IP Right Cessation
-
2002
- 2002-01-07 IL IL147505A patent/IL147505A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL352432A1 (en) | 2003-08-25 |
WO2001004116A2 (fr) | 2001-01-18 |
CZ200265A3 (cs) | 2002-07-17 |
AR034541A1 (es) | 2004-03-03 |
JP2003504367A (ja) | 2003-02-04 |
TW589311B (en) | 2004-06-01 |
CA2379149A1 (fr) | 2001-01-18 |
KR20020027486A (ko) | 2002-04-13 |
WO2001004116A3 (fr) | 2001-08-23 |
AU5485500A (en) | 2001-01-30 |
AU781235B2 (en) | 2005-05-12 |
EP1202990A2 (fr) | 2002-05-08 |
RU2241709C2 (ru) | 2004-12-10 |
HUP0202249A2 (hu) | 2002-12-28 |
BR0012327A (pt) | 2002-07-02 |
IL147505A (en) | 2006-07-05 |
MXPA02000330A (es) | 2004-05-21 |
CN1382140A (zh) | 2002-11-27 |
US6809107B1 (en) | 2004-10-26 |
HUP0202249A3 (en) | 2003-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL150550A0 (en) | 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists | |
EP1451173A4 (fr) | Piperidines | |
HK1065036A1 (en) | pyrrolidine and piperidine derivatives as nk1 antagonists | |
PL361463A1 (en) | Cyanopyrrolidine derivatives | |
SI1020464T1 (en) | Paroxetine methansulfonate | |
HUP0200811A2 (en) | Solid composition, its producing and using | |
IL147505A0 (en) | Neurotrophic pyrrolidines and piperidines, and related compositions and methods | |
IL143600A (en) | Il-174 polynucleotides, polypeptides and related compositions and methods | |
IL154422A0 (en) | Paroxetine compositions and processes for making the same | |
GB0016698D0 (en) | Tie | |
IL132862A0 (en) | New 4-substituted piperidines | |
ZA991038B (en) | Pyrrolidine and piperidine derivatives. | |
AU1018801A (en) | Use of 3,4-substituted piperidines | |
AU5606400A (en) | Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods | |
AU4566399A (en) | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents | |
AU4732001A (en) | Thiepino (3,2-b) dihydropyridines and related compositions and methods | |
AU5483500A (en) | Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods | |
EP1316549A4 (fr) | 1-benzyl-4-[(5,6-methoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine | |
EP1311709A4 (fr) | Methodes et compositions pour l'evolution moleculaire dirigee utilisant une modification des extremites de l'adn | |
GB9904614D0 (en) | Piperidines | |
HK1045506B (zh) | 氧硫庚英並[6,5-b]二氫吡啶和相關組合物及其製備方法 | |
GB9905907D0 (en) | Sterilant composition | |
PL337298A1 (en) | Paraffin-wax compositions | |
GB9904157D0 (en) | Mitre block | |
CA89270S (en) | Tie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |